Arcus Capital Partners LLC Increases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Arcus Capital Partners LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 31.1% during the first quarter, HoldingsChannel reports. The institutional investor owned 1,373 shares of the healthcare conglomerate’s stock after purchasing an additional 326 shares during the period. Arcus Capital Partners LLC’s holdings in UnitedHealth Group were worth $679,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Norden Group LLC increased its position in shares of UnitedHealth Group by 2,171.0% in the first quarter. Norden Group LLC now owns 100,149 shares of the healthcare conglomerate’s stock worth $49,547,000 after purchasing an additional 95,739 shares during the last quarter. Community Bank & Trust Waco Texas increased its position in shares of UnitedHealth Group by 11.4% in the first quarter. Community Bank & Trust Waco Texas now owns 13,784 shares of the healthcare conglomerate’s stock worth $6,819,000 after purchasing an additional 1,416 shares during the last quarter. Bourgeon Capital Management LLC grew its position in UnitedHealth Group by 27.8% during the first quarter. Bourgeon Capital Management LLC now owns 6,681 shares of the healthcare conglomerate’s stock valued at $3,305,000 after acquiring an additional 1,455 shares during the last quarter. Red Tortoise LLC grew its position in UnitedHealth Group by 45.1% during the first quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after acquiring an additional 23 shares during the last quarter. Finally, Meadow Creek Wealth Advisors LLC grew its position in UnitedHealth Group by 26.2% during the first quarter. Meadow Creek Wealth Advisors LLC now owns 2,214 shares of the healthcare conglomerate’s stock valued at $1,095,000 after acquiring an additional 460 shares during the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $489.89 on Thursday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $450.89 billion, a P/E ratio of 29.94, a P/E/G ratio of 1.47 and a beta of 0.60. The business has a fifty day simple moving average of $498.64 and a two-hundred day simple moving average of $501.12. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company’s revenue for the quarter was up 8.6% on a year-over-year basis. During the same quarter last year, the firm posted $6.26 earnings per share. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.71%. The ex-dividend date of this dividend was Monday, June 17th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is currently 51.34%.

Analyst Ratings Changes

A number of research analysts have commented on the stock. TD Cowen reduced their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Bank of America restated a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 target price on the stock in a report on Wednesday, June 5th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a report on Wednesday, June 12th. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.